title: How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
authors.affiliation: Palliative Care Program, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
authors.forename: R L
authors.initials: RL
authors.lastname: Fainsinger
authors.forename: E
authors.initials: E
authors.lastname: Bruera
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000494:pharmacology; D002170:Canada; D002648:Child; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010166:Palliative Care
chemical_list: D000701:Analgesics, Opioid; D005283:Fentanyl